Wang Y, Li J, Yang Y, Lu X, et al. Letrozole plus anlotinib as a chemotherapy-free regimen for ER-positive platinum-resistant recurrent epithelial ovarian cancer patients following second-line platinum-based chemotherapy failure: A prospective, single-arm, open-label, phase II study. Gynecol Oncol 2025;203:67-74.
PMID: 41166983